A study conducted in colorectal cancer cells (HCT116 and DLD1) showed that the combined treatment increases cell cycle arrest and decreases the proliferation and migration of colorectal cancer cells by inhibiting the PI3K/Akt signaling pathway. This evidence concerns the gene AKT1 and colorectal cancer.